FSA
FURX

Franklin Street Advisors’s FURIEX PHARMACEUTICALS INC COM STK (DE) FURX Stock Holding History

Franklin Street Advisors’s Portfolio FURX Stock Details FURX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-48,755
Closed -$5.18M – 241
2014
Q2 		$5.18M Sell
48,755
-300
-0.6% -$29.4K 0.99% 33
2014
Q1 		$4.27M Sell
49,055
-3,270
-6% -$252K 0.85% 40
2013
Q4 		$2.2M Buy
52,325
+8,375
+19% +$344K 0.44% 65
2013
Q3 		$1.93M Sell
43,950
-1,500
-3% -$62.1K 0.43% 69
2013
Q2 		$1.55M Buy
+45,450
New +$1.6M 0.38% 71

Franklin Street Advisors's FURX Position: Q3 2014 in Review

Franklin Street Advisors sold out of FURIEX PHARMACEUTICALS INC COM STK (DE) (FURX) in Q3 2014, closing a stake of 48,755 shares — an estimated $5.18M sold.

Franklin Street Advisors first reported a position in FURX in Q2 2013 and held it in 5 quarters. The position peaked at $5.18M in Q2 2014. 0 funds tracked by Wall St. Rank hold FURX as of Q3 2014.

  • Franklin Street Advisors reported no remaining FURIEX PHARMACEUTICALS INC COM STK (DE) position as of Q3 2014 after selling out during the quarter.
  • Franklin Street Advisors sold 48,755 FURIEX PHARMACEUTICALS INC COM STK (DE) shares in Q3 2014, an estimated $5.18M.
  • Franklin Street Advisors first reported a position in FURIEX PHARMACEUTICALS INC COM STK (DE) in Q2 2013 and held it in 5 quarters.
  • Franklin Street Advisors's FURIEX PHARMACEUTICALS INC COM STK (DE) position peaked at $5.18M in Q2 2014.
  • 0 funds tracked by Wall St. Rank held FURIEX PHARMACEUTICALS INC COM STK (DE) as of Q3 2014.

Based on Franklin Street Advisors's 13F filing for Q3 2014, filed 7 Oct 2014.